-
-
-
-
-
-
-
PepsiCo Scraps Coverage of Weight-Loss Drugs for Employees - Bloomberg
-
-
-
-
-
-
-
Eli Lilly (LLY) PT Raised to $1,400 at BMO Capital
-
-
-
-
-
-
-
FDA grants Lilly's olomorasib breakthrough therapy status for pancreatic cancer
-
-
-
-
-
-
-
Oppenheimer on AtaiBeckley Inc (ATAI): 'LLY Acquisition Validates Psychedelic Advantages'
-
-
-
-
-
-
-
Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
-
-
-
-
-
-
-
FDA selects 7 companies for domestic drug manufacturing pilot
-
-
-
-
-
-
-
Oral Wegovy reaches 33% of total prescriptions by May
-
458,121 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

